A Trial of Skin Care Protocols for Facial Resurfacing (SPAR)

The Plastic Surgery Foundation

Status and phase: Completed; Phase 4

Conditions: Periocular Fine Wrinkles; Facial Photo Damage; Perioral Fine Wrinkles

Treatments: Other: Obagi New-Derm System; Other: Standard of Care

Study type: Interventional

Funder types: Other

Identifiers

NCT01113606

PSEF001-06

Details and patient eligibility

About

The aims of the Skin Product Assessment Research study were to (1) develop an infrastructure and process for industry-sponsored, Plastic Surgery Educational Foundation (PSEF) research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System (ODNS) and conventional therapy as treatment adjuncts in ablative facial resurfacing.

Sex: Female

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients with moderate to severe photo damage and rhytids, undergoing full or partial face resurfacing with chemical peel or ablative laser.
• Fitzpatrick I-IV skin types

Exclusion criteria

• patients unable to complete the regimen or who had used topical prescription steroids, retinoids, depigmentation products or other products containing hydroquinone and polyhydroxy acids within 8 weeks of enrollment.

Trial design

0 participants in 2 patient groups

Obagi Nu-Derm System (ONDS)

Active Comparator group

Treatment:

Other: Obagi New-Derm System

Standard of Care

Active Comparator group

Treatment:

Other: Standard of Care